Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Advanced Sarcoma
- Dedifferentiated Liposarcoma
- High Grade Sarcoma
- Leiomyosarcoma
- Myxofibrosarcoma
- Sarcoma
- Undifferentiated Pleomorphic Sarcoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: Standard 3+3 designMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04242238
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sandra D'Angelo, MD Memorial Sloan Kettering Cancer Center